Patents by Inventor Peter Nigel Black

Peter Nigel Black has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of lactic acid bacteria to treat or prevent eczema
    Patent number: 9737575
    Abstract: Use of Lactobacillus rhamnosus HN001 or derivatives thereof to treat or prevent eczema.
    Type: Grant
    Filed: November 28, 2008
    Date of Patent: August 22, 2017
    Assignee: UNIVERSITY OF OTAGO
    Inventors: Julian Crane, Angela Marie Rowan, Kristin Lee Wickens, Gerald William Tannock, Thorsten Villiers Stanley, Penelope Frances Fitzharris, Edwin Arthur Mitchell, Peter Nigel Black, Bernadette Salmon
  • USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT ECZEMA
    Publication number: 20120045422
    Abstract: Use of Lactobacillus rhamnosus HN001 or derivatives thereof to treat or prevent eczema.
    Type: Application
    Filed: November 28, 2008
    Publication date: February 23, 2012
    Applicant: UNIVERSITY OF OTAGO
    Inventors: Julian Crane, Angela Marie Rowan, Kristin Lee Wickens, Gerald William Tannock, Thorsten Villiers Stanley, Penelope Frances Fitzharris, Edwin Arthur Mitchell, Peter Nigel Black, Bernadette Salmon
  • COMPOSITIONS OF CIS-9, TRANS-11 CONJUGATED LINOLEIC ACID AND VACCENIC ACID AND USES THEREOF
    Publication number: 20090048339
    Abstract: The invention relates to use of the cis-9, trans-11 isomer of conjugated linoleic acid or a salt or ester thereof (cis-9, trans-11 CLA) and vaccenic acid or a salt or ester thereof (VA) to treat or prevent conditions associated with one or more of leukocyte infiltration, eosinophilia, airway remodelling, bronchoconstriction, mucus hypersecretion, and lung and skin inflammation. The present invention also relates to a composition comprising cis-9, trans-11 CLA and VA and use of the composition to treat or pre-vent conditions associated with one or more of leukocyte infiltration, eosinophilia, airway remodelling, bronchoconstriction, mucus hypersecretion, and lung and skin inflammation. In particular, the medicinal uses, compositions and methods of the invention may be used to treat or prevent conditions such as asthma and dermatitis, and related disorders.
    Type: Application
    Filed: November 10, 2006
    Publication date: February 19, 2009
    Applicants: FONTERRA CORPORATE RESEARCH AND DEVELOPMENT LIMITE, FONTERRA LIMITED, AUCKLAND UNISERVICES LIMITED
    Inventors: Rupinder Kaur Kanwar, Geoffrey Wayne Krissansen, Peter Nigel Black, Alastair Kenneth Hugh MacGibbon
  • Cla-Enriched Milkfat and Uses Thereof
    Publication number: 20080193550
    Abstract: The present invention relates to use of c-9, t-11 CLA or a salt, ester or precursor thereof or CLA-enriched milk fat comprising milk fat enriched with c-9, t-11 CLA or a salt, ester or precursor thereof for treating or preventing conditions such as those associated with one or more of leukocyte infiltration, eosinophilia, IgE secretion, airway remodelling, bronchoconstriction and mucus hypersecretion. The invention also relates to a pharmaceutical composition comprising CLA-enriched milk fat.
    Type: Application
    Filed: May 11, 2005
    Publication date: August 14, 2008
    Applicants: FONTERRA CORPORATE RESEARCH AND DEVELOPMENT LIMITED, AUCKLAND UNISERVICES LIMITED
    Inventors: Alastair Kenneth Hugh MacGibbon, Geoffrey Wayne Krissansen, Rupinder Kaur Kanwar, Peter Nigel Black